ASMS Plenary Lectures
Both of these Plenary session talks will take place in Hall D, ground level.
Sunday’s plenary session opens with a welcome talk from ASMS vice president for programs, Richard A. Yost. Following Yost, Lisa Shipley, vice president and global head of pharmacokinetics, pharmacodynamics, and drug metabolism at Merck, will give a plenary session talk titled “Pharmacokinetics, Pharmacodynamics & Drug Metabolism.” The talk begins at 6:45.
Later in the week, Larry Bowers of LD Bowers, LLC will speak at another plenary session on Thursday at 4:45 pm. Bowers is well known for his work fighting sports doping during his tenure as the chief scientific officer of the US Anti-Doping Agency. The title of Bowers’ talk is “The Fight Against Doping: From Strychnine to Turinabol.” Richard A. Yost will host the session.
Both of these plenary session talks will take place in Hall D, ground level.
Navigating the Impact of Funding Cuts: Voices from the Research Community
July 9th 2025Shifts in U.S. federal science funding—driven by the newly established Department of Government Efficiency (DOGE)—are causing delays, uncertainty, and program changes across academic and regulatory research institutions.
